|
| L-Nateglinide Basic information |
Product Name: | L-Nateglinide | Synonyms: | L-Nateglinide;L-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, trans-;L-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]- (9CI);ent-Nateglinide;N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine;Nateglinide Related CoMpound B;Nateglinide Related Compound B (10 mg) (N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine);N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-L-phenylalanine | CAS: | 105816-05-5 | MF: | C19H27NO3 | MW: | 317.42 | EINECS: | | Product Categories: | Amino Acids & Derivatives;Metabolites & Impurities | Mol File: | 105816-05-5.mol | |
| L-Nateglinide Chemical Properties |
Melting point | 103-111°C | Boiling point | 527.6±39.0 °C(Predicted) | density | 1.104±0.06 g/cm3(Predicted) | storage temp. | -20°C Freezer | solubility | DMSO (Slightly), Methanol (Slightly) | pka | 3.61±0.10(Predicted) | color | White to Off-White |
Hazard Codes | Xi | Risk Statements | 36/37/38 | Safety Statements | 26 | HS Code | 2924296000 |
| L-Nateglinide Usage And Synthesis |
Chemical Properties | White to Off-White Solid | Uses | An impurity found within the commercial pharmaceutical Nateglinide (N379375), a common antidiabetic | Uses | An impurity found within the commercial pharmaceutical Nateglinide (N379375), a novel D-phenylalanine-derivative hypoglycemic agent. Nateglinide USP Related Compound B | Definition | ChEBI: (2S)-2-[[oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic acid is a phenylalanine derivative. |
| L-Nateglinide Preparation Products And Raw materials |
|